Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6526-78-9

Post Buying Request

6526-78-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6526-78-9 Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 95, p. 4083, 1973 DOI: 10.1021/ja00793a062

Check Digit Verification of cas no

The CAS Registry Mumber 6526-78-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,2 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6526-78:
(6*6)+(5*5)+(4*2)+(3*6)+(2*7)+(1*8)=109
109 % 10 = 9
So 6526-78-9 is a valid CAS Registry Number.

6526-78-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methylcyclohexan-1-amine

1.2 Other means of identification

Product number -
Other names 1-Methylcyclohexanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6526-78-9 SDS

6526-78-9Relevant articles and documents

-

Kovacic,P.,Chaudhary,S.S.

, p. 3563 - 3571 (1967)

-

METHODS OF TREATING CNS DISORDERS

-

, (2009/12/02)

The present invention relates to methods of treating various CNS disorders, e.g., mania, bipolar disorder and schizophrenia, by administering NMDA receptor antagonists, alone or in combination with dopamine receptor antagonists.

Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors

-

, (2008/06/13)

The invention relates to a novel drug combination therapy useful in the treatment of dementia comprising administering an 1-aminocyclohexane derivative such as memantine or neramexane and an acetylcholinesterase inhibitor (AChEI) such as galantamine, tacrine, donepezil, or rivastigmine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6526-78-9